{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:05:21Z","timestamp":1791554721705,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Liggins Institute, University of Auckland, New Zealand"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41372-025-02463-2","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:26:44Z","timestamp":1762342004000},"page":"638-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral doxapram for apnea of prematurity: A randomized dosage trial"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-9564","authenticated-orcid":false,"given":"Jane M.","family":"Canning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Hannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julena","family":"Ardern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Mravicich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4893-6951","authenticated-orcid":false,"given":"Trusha J.","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1903-254X","authenticated-orcid":false,"given":"Naibo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7553-2613","authenticated-orcid":false,"given":"Sara M.","family":"Hanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1088-9467","authenticated-orcid":false,"given":"Christopher J. D.","family":"McKinlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2463_CR1","doi-asserted-by":"publisher","unstructured":"Eichenwald EC. Apnea of prematurity. Pediatrics. 2016;137. https:\/\/doi.org\/10.1542\/peds.2015-3757.","DOI":"10.1542\/peds.2015-3757"},{"key":"2463_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1440-1754.1981.tb01957.x","volume":"17","author":"DJ Henderson-Smart","year":"1981","unstructured":"Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. J Paediatr Child Health. 1981;17:273\u20136.","journal-title":"J Paediatr Child Health"},{"key":"2463_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/pr.1991.72500","volume":"29","author":"K Barrington","year":"1991","unstructured":"Barrington K, Finer N. The natural history of the appearance of apnea of prematurity. Pediatr Res. 1991;29:372\u20135.","journal-title":"Pediatr Res"},{"key":"2463_CR4","doi-asserted-by":"publisher","first-page":"S377","DOI":"10.1016\/S1526-0542(04)90067-X","volume":"5","author":"RJ Martin","year":"2004","unstructured":"Martin RJ, Abu-Shaweesh JM, Baird TM. Apnoea of prematurity. Paediatr Respir Rev. 2004;5:S377\u2013S82.","journal-title":"Paediatr Respir Rev"},{"key":"2463_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.jp.7211182","volume":"24","author":"A Janvier","year":"2004","unstructured":"Janvier A, Khairy M, Kokkotis A, Cormier C, Messmer D, Barrington KJ. Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol. 2004;24:763\u20138.","journal-title":"J Perinatol"},{"key":"2463_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/jama.2015.8841","volume":"314","author":"CF Poets","year":"2015","unstructured":"Poets CF, Roberts RS, Schmidt B, Whyte RK, Asztalos EV, Bader D, et al. Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants. J Am Med Assoc. 2015;314:595\u2013603.","journal-title":"J Am Med Assoc"},{"key":"2463_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0022-3476(85)80475-3","volume":"106","author":"MJ Miller","year":"1985","unstructured":"Miller MJ, Carlo WA, Martin RJ. Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants. J Pediatrics. 1985;106:91\u20134.","journal-title":"J Pediatrics"},{"key":"2463_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpeds.2020.03.015","volume":"222","author":"KZ Kovatis","year":"2020","unstructured":"Kovatis KZ, Di Fiore JM, Martin RJ, Abbasi S, Chaundhary AS, Hoover S, et al. Effect of Blood Transfusions on Intermittent Hypoxic Episodes in a Prospective Study of Very Low Birth Weight Infants. J Pediatr. 2020;222:65\u201370.","journal-title":"J Pediatr"},{"key":"2463_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jpeds.2012.02.044","volume":"161","author":"K Zagol","year":"2012","unstructured":"Zagol K, Lake DE, Vergales B, Moorman ME, Paget-Brown A, Lee H, et al. Anemia, apnea of prematurity, and blood transfusions. J Pediatr. 2012;161:417\u201321.","journal-title":"J Pediatr"},{"key":"2463_CR10","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine Therapy for Apnea of Prematurity. N Engl J Med. 2006;354:2112\u201321.","journal-title":"N Engl J Med"},{"key":"2463_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113488","volume":"259","author":"B Schmidt","year":"2023","unstructured":"Schmidt B. Caffeine for Apnea of Prematurity: Too Much or Too Little of a Good Thing. J Pediatr. 2023;259:113488.","journal-title":"J Pediatr"},{"key":"2463_CR12","doi-asserted-by":"crossref","unstructured":"Storm KK, Flint RB, Onland W, Van Kaam AH, Reiss IKM, Hutten GJ, et al. Caffeine therapy for apnea of prematurity: single-center study on dosing practices and perceived effectiveness. Neonatology. 2024:290\u2013301.","DOI":"10.1159\/000543074"},{"key":"2463_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/251047","volume":"2013","author":"SA Prins","year":"2013","unstructured":"Prins SA, Pans SJA, van Weissenbruch MM, Walther FJ, Simons SHP. Doxapram Use for Apnoea of Prematurity in Neonatal Intensive Care. Int J Pediatr. 2013;2013:1\u20135.","journal-title":"Int J Pediatr"},{"key":"2463_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/apa.13761","volume":"106","author":"R Flint","year":"2017","unstructured":"Flint R, Halbmeijer N, Meesters N, van Rosmalen J, Reiss I, van Dijk M, et al. Retrospective study shows that doxapram therapy avoided the need for endotracheal intubation in most premature neonates. Acta Paediatr. 2017;106:733\u20139.","journal-title":"Acta Paediatr"},{"key":"2463_CR15","first-page":"359","volume":"11","author":"LP Brion","year":"1991","unstructured":"Brion LP, Vega-Rich C, Reinersman G, Roth P. Low-dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants. J Perinatol J Calif Perinat Assoc. 1991;11:359\u201364.","journal-title":"J Perinatol J Calif Perinat Assoc"},{"key":"2463_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1542\/peds.78.3.540","volume":"78","author":"GD Jordan","year":"1986","unstructured":"Jordan GD, Themelis NJ, Messerly SO, Jarrett RV, Garcia J, Frank CG. Doxapram and potential benzyl alcohol toxicity: a moratorium on clinical investigation?. Pediatrics. 1986;78:540\u20131.","journal-title":"Pediatrics"},{"key":"2463_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-2007-999357","volume":"8","author":"A Bairam","year":"1991","unstructured":"Bairam A, Akramoff-Gershan L, Beharry K, Laudignon N, Papageorgiou A, Aranda J. Gastrointestinal Absorption of Doxapram in Neonates. Am J Perinatol. 1991;8:110\u20133.","journal-title":"Am J Perinatol"},{"key":"2463_CR18","first-page":"123","volume":"17","author":"MG Romeo","year":"1995","unstructured":"Romeo MG, Betta P, Tina LG, Cilauro S, Saporito A, Distefano G. Oral administration of doxapram in preterm neonates with aminophylline-resistant idiopathic apnea crisis. La Pediatr Med e Chirurgica: Med Surgical Pediatrics. 1995;17:123\u20136.","journal-title":"La Pediatr Med e Chirurgica: Med Surgical Pediatrics"},{"key":"2463_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000014160","volume":"76","author":"CF Poets","year":"1999","unstructured":"Poets CF, Darraj S, Bohnhorst B. Effect of Doxapram on Episodes of Apnoea, Bradycardia and Hypoxaemia in Preterm Infants. Neonatology. 1999;76:207\u201313.","journal-title":"Neonatology"},{"key":"2463_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000243342","volume":"59","author":"J Tay-Uyboco","year":"1991","unstructured":"Tay-Uyboco J, Kwiatkowski K, Cates DB, Seifert B, Hasan SU, Rigatto H. Clinical and Physiological Responses to Prolonged Nasogastric Administration of Doxapram for Apnea of Prematurity. Neonatology. 1991;59:190\u2013200.","journal-title":"Neonatology"},{"key":"2463_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5055\/jom.2020.0567","volume":"16","author":"MDRQ Baloch","year":"2020","unstructured":"Baloch MDRQ, Pinto MDJM, Greenberg MSP, Kuo PY-H, Siu PBA. Evaluation and analysis of the Modified Finnegan Scoring System for assessment of neonatal abstinence syndrome. J Opioid Manag. 2020;16:189\u201396.","journal-title":"J Opioid Manag"},{"key":"2463_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/archdischild-2022-324010","volume":"108","author":"EA Oliphant","year":"2023","unstructured":"Oliphant EA, McKinlay CJD, McNamara D, Cavadino A, Alsweiler JM. Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial. Arch Dis Child Fetal Neonatal Ed. 2023;108:106\u201313.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2463_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s004670050771","volume":"14","author":"JT Flynn","year":"2000","unstructured":"Flynn JT. Neonatal hypertension: diagnosis and management. Pediatr Nephrol. 2000;14:332\u201341.","journal-title":"Pediatr Nephrol"},{"key":"2463_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24180","volume":"24","author":"J Dorling","year":"2020","unstructured":"Dorling J, Hewer O, Hurd M, Bari V, Bosiak B, Bowler U, et al. Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: The SIFT RCT. Health Technol Assess. 2020;24:1\u201394.","journal-title":"Health Technol Assess"},{"key":"2463_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/jp.2009.55","volume":"29","author":"AL Patel","year":"2009","unstructured":"Patel AL, Engstrom JL, Meier PP, Jegier BJ, Kimura RE. Calculating postnatal growth velocity in very low birth weight (VLBW) premature infants. J Perinatol. 2009;29:618\u201322.","journal-title":"J Perinatol"},{"key":"2463_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/adc.69.1_Spec_No.32","volume":"69","author":"SJ Newell","year":"1993","unstructured":"Newell SJ, Chapman S, Booth IW. Ultrasonic assessment of gastric emptying in the preterm infant. Arch Dis Child. 1993;69:32\u20136.","journal-title":"Arch Dis Child"},{"key":"2463_CR27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s00247-004-1285-6","volume":"34","author":"E Robel-Tillig","year":"2004","unstructured":"Robel-Tillig E, Kn\u00fcpfer M, Pulzer F, Vogtmann C. Blood flow parameters of the superior mesenteric artery as an early predictor of intestinal dysmotility in preterm infants. Pediatr Radio. 2004;34:958\u201362.","journal-title":"Pediatr Radio"},{"key":"2463_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1542\/peds.80.1.22","volume":"80","author":"KJ Barrington","year":"1987","unstructured":"Barrington KJ, Finer NN, Torok-Both G, Jamali F, Coutts RT. Dose-Response Relationship of Doxapram in the Therapy for Refractory Idiopathic Apnea of Prematurity. Pediatrics. 1987;80:22\u20137.","journal-title":"Pediatrics"},{"key":"2463_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000457668","volume":"11","author":"MA Beaudry","year":"1988","unstructured":"Beaudry MA, Bradley JM, Gramlich LM, LeGatt D. Pharmacokinetics of Doxapram in Idiopathic Apnea of Prematurity. Dev Pharm Ther. 1988;11:65\u201372.","journal-title":"Dev Pharm Ther"},{"key":"2463_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00007691-199910000-00011","volume":"21","author":"F Barb\u00e9","year":"1999","unstructured":"Barb\u00e9 F, Hansen C, Badonnel Y, Legagneur H, Vert P, Boutroy M-J. Severe Side Effects and Drug Plasma Concentrations in Preterm Infants Treated With Doxapram. Ther Drug Monit. 1999;21:547.","journal-title":"Ther Drug Monit"},{"key":"2463_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0022-3476(86)80594-7","volume":"109","author":"F Hayakawa","year":"1986","unstructured":"Hayakawa F, Hakamada S, Kuno K, Nakashima T, Miyachi Y. Doxapram in the treatment of idiopathic apnea of prematurity: Desirable dosage and serum concentrations. J Pediatrics. 1986;109:138\u201340.","journal-title":"J Pediatrics"},{"key":"2463_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000243744","volume":"61","author":"A Bairam","year":"1992","unstructured":"Bairam A, Faulon M, Monin P, Vert P. Doxapram for the initial treatment of idiopathic apnea of prematurity. Biol Neonate. 1992;61:209\u201313.","journal-title":"Biol Neonate"},{"key":"2463_CR33","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1378\/chest.85.5.600","volume":"85","author":"NK Burki","year":"1984","unstructured":"Burki NK. Ventilatory Effects of Doxapram in Conscious Human Subjects. Chest. 1984;85:600\u20134.","journal-title":"Chest"},{"key":"2463_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/cs057021Pb","volume":"57","author":"PMA Calverley","year":"1979","unstructured":"Calverley PMA, Robson RH, Wraith PK, Prescott LF, Flenley DC. The Ventilatory Effects of Doxapram in Hypoxia and Hypercapnia in Normal Man. Clin Sci. 1979;57:21\u20132P.","journal-title":"Clin Sci"},{"key":"2463_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF01061418","volume":"34","author":"S Okubo","year":"1988","unstructured":"Okubo S, Konno K, Ishizaki T, Suganuma T, Takubo T, Takizawa T, et al. Serum doxapram and respiratory neuromuscular drive in normal man. Eur J Clin Pharm. 1988;34:55\u20139.","journal-title":"Eur J Clin Pharm"},{"key":"2463_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40272-016-0192-2","volume":"18","author":"E Greze","year":"2016","unstructured":"Greze E, Benard M, Hamon I, Casper C, Haddad FE, Boutroy MJ, et al. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial. Pediatr Drugs. 2016;18:443\u20139.","journal-title":"Pediatr Drugs"},{"key":"2463_CR37","first-page":"142","volume":"28","author":"A Bairam","year":"1990","unstructured":"Bairam A, Blanchard PW, Mullahoo K, Beharry K, Laudignon N, Aranda JV. Pharmacodynamic Effects and Pharmacokinetic Profiles of Keto-Doxapram and Doxapram in Newborn Lambs. Pediatr Res. 1990;28:142\u20136.","journal-title":"Pediatr Res"},{"key":"2463_CR38","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41390-020-1037-9","volume":"89","author":"RB Flint","year":"2021","unstructured":"Flint RB, Simons SHP, Andriessen P, Liem KD, Degraeuwe PLJ, Reiss IKM, et al. The bioavailability and maturing clearance of doxapram in preterm infants. Pediatr Res. 2021;89:1268\u201377.","journal-title":"Pediatr Res"},{"key":"2463_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07683-5","volume":"24","author":"JA Poppe","year":"2023","unstructured":"Poppe JA, Flint RB, Smits A, Willemsen SP, Storm KK, Nuytemans DH, et al. Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial). Trials. 2023;24:656.","journal-title":"Trials"},{"key":"2463_CR40","unstructured":"Health Information Standards Organisation. HISO 10001: 2017 ethnicity data protocols. Wellington; 2017."}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02463-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02463-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02463-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:51:43Z","timestamp":1777290703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02463-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2463"],"URL":"https:\/\/doi.org\/10.1038\/s41372-025-02463-2","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Northern A Health and Disability Ethics Committee of New Zealand (21\/NTA\/136). Parents or guardians provided prospective written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}